[
    {
        "molecule_name": "5-(3-(2,6-Dimethylbenzyloxy)phenyl)-1H-tetrazole",
        "protein_target_name": "URAT1",
        "binding_metric": "IC50",
        "value": "0.93",
        "unit": "μM",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\n\nFor assessment of activity of compounds as URAT1 inhibitors, the percent inhibition of uric acid uptake was typically assessed at a drug concentration of 10 micromolar (Table1).\nTABLE 1Inhibitory effects of the test compounds at the concentration of10 μM on <sup>14</sup>C urate uptake in hURAT1-HEK cellsTest Compound% of InhibitionS.D.EB90.00.29EC95.20.67ED960.7EF920.6EG95.570.39BD56.572.64EH80.001.29EI44.001.53\nTABLE 2CompoundIC50 values (μM)EB0.93EC0.24ED0.25EF0.74EG0.13Benzbromarone0.75Probenecid174"
    },
    {
        "molecule_name": "5-(3-(2,6-Dimethylbenzyloxy)benzyl)-1H-tetrazole",
        "protein_target_name": "URAT1",
        "binding_metric": "IC50",
        "value": "0.24",
        "unit": "μM",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\n\nFor assessment of activity of compounds as URAT1 inhibitors, the percent inhibition of uric acid uptake was typically assessed at a drug concentration of 10 micromolar (Table1).\nTABLE 1Inhibitory effects of the test compounds at the concentration of10 μM on <sup>14</sup>C urate uptake in hURAT1-HEK cellsTest Compound% of InhibitionS.D.EB90.00.29EC95.20.67ED960.7EF920.6EG95.570.39BD56.572.64EH80.001.29EI44.001.53\nTABLE 2CompoundIC50 values (μM)EB0.93EC0.24ED0.25EF0.74EG0.13Benzbromarone0.75Probenecid174"
    },
    {
        "molecule_name": "5-(3-(2,6-Dimethylbenzyloxy)-4-methoxybenzyl)-1H-tetrazole",
        "protein_target_name": "URAT1",
        "binding_metric": "IC50",
        "value": "0.25",
        "unit": "μM",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\n\nFor assessment of activity of compounds as URAT1 inhibitors, the percent inhibition of uric acid uptake was typically assessed at a drug concentration of 10 micromolar (Table1).\nTABLE 1Inhibitory effects of the test compounds at the concentration of10 μM on <sup>14</sup>C urate uptake in hURAT1-HEK cellsTest Compound% of InhibitionS.D.EB90.00.29EC95.20.67ED960.7EF920.6EG95.570.39BD56.572.64EH80.001.29EI44.001.53\nTABLE 2CompoundIC50 values (μM)EB0.93EC0.24ED0.25EF0.74EG0.13Benzbromarone0.75Probenecid174"
    },
    {
        "molecule_name": "5-(3-(2,6-Dimethylbenzyloxy)phenethyl)-1H-tetrazole",
        "protein_target_name": "URAT1",
        "binding_metric": "IC50",
        "value": "0.74",
        "unit": "μM",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\n\nFor assessment of activity of compounds as URAT1 inhibitors, the percent inhibition of uric acid uptake was typically assessed at a drug concentration of 10 micromolar (Table1).\nTABLE 1Inhibitory effects of the test compounds at the concentration of10 μM on <sup>14</sup>C urate uptake in hURAT1-HEK cellsTest Compound% of InhibitionS.D.EB90.00.29EC95.20.67ED960.7EF920.6EG95.570.39BD56.572.64EH80.001.29EI44.001.53\nTABLE 2CompoundIC50 values (μM)EB0.93EC0.24ED0.25EF0.74EG0.13Benzbromarone0.75Probenecid174"
    },
    {
        "molecule_name": "5-(3-(2,6-Dimethylbenzyloxy)-4-methylbenzyl)-1H-tetrazole",
        "protein_target_name": "URAT1",
        "binding_metric": "IC50",
        "value": "0.13",
        "unit": "μM",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\n\nFor assessment of activity of compounds as URAT1 inhibitors, the percent inhibition of uric acid uptake was typically assessed at a drug concentration of 10 micromolar (Table1).\nTABLE 1Inhibitory effects of the test compounds at the concentration of10 μM on <sup>14</sup>C urate uptake in hURAT1-HEK cellsTest Compound% of InhibitionS.D.EB90.00.29EC95.20.67ED960.7EF920.6EG95.570.39BD56.572.64EH80.001.29EI44.001.53\nTABLE 2CompoundIC50 values (μM)EB0.93EC0.24ED0.25EF0.74EG0.13Benzbromarone0.75Probenecid174"
    },
    {
        "molecule_name": "3-(2-Bromo-4,5-dihydro-5-(2-methoxyphenyl)-2-oxazolyl)benzoic acid",
        "protein_target_name": "URAT1",
        "binding_metric": "IC50",
        "value": "0.75",
        "unit": "μM",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\n\nFor assessment of activity of compounds as URAT1 inhibitors, the percent inhibition of uric acid uptake was typically assessed at a drug concentration of 10 micromolar (Table1).\nTABLE 1Inhibitory effects of the test compounds at the concentration of10 μM on <sup>14</sup>C urate uptake in hURAT1-HEK cellsTest Compound% of InhibitionS.D.EB90.00.29EC95.20.67ED960.7EF920.6EG95.570.39BD56.572.64EH80.001.29EI44.001.53\nTABLE 2CompoundIC50 values (μM)EB0.93EC0.24ED0.25EF0.74EG0.13Benzbromarone0.75Probenecid174"
    },
    {
        "molecule_name": "4-((Dipropylamino)sulfonyl)benzoic acid",
        "protein_target_name": "URAT1",
        "binding_metric": "IC50",
        "value": "174",
        "unit": "μM",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\n\nFor assessment of activity of compounds as URAT1 inhibitors, the percent inhibition of uric acid uptake was typically assessed at a drug concentration of 10 micromolar (Table1).\nTABLE 1Inhibitory effects of the test compounds at the concentration of10 μM on <sup>14</sup>C urate uptake in hURAT1-HEK cellsTest Compound% of InhibitionS.D.EB90.00.29EC95.20.67ED960.7EF920.6EG95.570.39BD56.572.64EH80.001.29EI44.001.53\nTABLE 2CompoundIC50 values (μM)EB0.93EC0.24ED0.25EF0.74EG0.13Benzbromarone0.75Probenecid174"
    }
]